News & Updates
News 09.06.2023

PRESS RELEASE: OVER 150 HIV ORGANIZATIONS DENOUNCE DRASTIC CUTS TO DOMESTIC FUNDING AND THREATS TO GLOBAL CARE AND PREVENTION

For Immediate Release Media Inquiries: Michael Chancley, Michael@PrEP4All.org, Washington DC– On Tuesday, September 5th, global and national HIV organizations held a press conference at the US Capitol to denounce catastrophic domestic HIV funding cuts proposed by the US House of Representatives and threats to global HIV funding. Advocates urged members of Congress to support and […]
News 08.02.2023

PrEP4All Applauds Announcement of Pioneering PrEP Researcher to Lead NIAID

For Immediate Release Wednesday, August 2nd, 2023 For media inquiries please email Michael Chancley at Michael@PrEP4All.org  PrEP4All welcomes the announcement of Dr. Jeanne Marrazzo to fill the role of Director at the National Institute of Allergy and Infectious Diseases (NIAID), a post that was previously held for almost four decades by Dr. Anthony Fauci. The […]
News 07.31.2023

Activist Victory: PrEP4All, AVAC, HIVMA, and the PrEP In Black America Coalition Applaud Senate Proposal to Increase Key HIV Funding, Build National PrEP Program

For Immediate Release Friday, July 28, 2023  For Media Inquiries, contact Michael Chancley at michael@prep4all.org. Soundly rejecting House efforts to gut HIV funding, yesterday the Senate Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Subcommittee released its FY24 spending bill which clearly reflects concerted efforts by PrEP activists over the past few […]
News 07.26.2023

NYTimes: Years Ago, PrEP4All Correctly Called Out Gilead’s Intentional Delay In Developing Potentially Safer HIV Treatment to US Patent and Trademark Office

July 25th, 2023– For media requests please email Jeremiah Johnson at  Jeremiah@PrEP4All.org or Chris Morten at cjm2002@columbia.edu  On Saturday July 22, a New York Times front-page investigation published “smoking gun” documents that confirm PrEP4All’s longstanding analysis of Gilead Pharmaceuticals’ unethical decision to stop development of a potentially safer version of a key HIV medication, tenofovir, […]
News 07.13.2023

PrEP4All and the Elton John AIDS Foundation Announce Strategic Partnership to Advance a National PrEP Program

Thursday, July 13th, 2023.  For media inquiries please contact Michael Chancley at Michael@PrEP4All.org  PrEP4All is proud to announce that our work to ensure equitable PrEP access for all in the United States will be supported by a two-year investment totaling nearly $670,000 from the Elton John AIDS Foundation. This new strategic partnership comes at a […]
Statement 05.17.2023

Statement from PrEP4All and PIPLI on the Disappointing Verdict in US v. Gilead

For media inquiries contact: Jeremiah Johnson (Jeremiah@PrEP4All.org) or Chris Morten (cjm2002@columbia.edu) PrEP4All and the Public Interest Patent Law Institute (PIPLI), along with their legal representatives at Columbia Law School’s Science, Health, and Information Clinic, are deeply disappointed in yesterday’s verdict in United States v. Gilead. The United States v. Gilead case creates an opportunity to […]
News 05.17.2023

Press Release: PrEP Advocates Convene Virtual Town Hall Responding to Braidwood v. Becerra

Media Inquiries: Jeremiah Johnson- Jeremiah@PrEP4All.org; Kyra Sanborn- ksanborn@law.harvard.edu; Kay Marshall- kaymarshall@mac.com Thursday, April 6th, 2023, New York, NY— Hundreds of HIV prevention advocates nationwide convened on Tuesday to discuss the implications of Judge Reed O’Connor’s ruling in the Texas Braidwood v. Becerra case that could impact access to PrEP and other preventive health interventions for […]
News 02.08.2023

PRESS RELEASE: Black HIV Advocates Release “Master Plan for HIV Prevention” and Announce Next PrEP In Black America Summit in New Orleans, LA

On National Black HIV/AIDS Awareness Day (Feb. 7), Black HIV Prevention advocates released “For Us By Us: PrEP In Black America: A Master Plan for HIV Prevention In Black America”, a roadmap to drastically scale-up use of pre-exposure prophylaxis (PrEP) in the Black community. PrEP is a biomedical tool used to reduce the risk of acquiring HIV by over 99%.

Statement 01.18.2023

Update: PrEP4All Submits Public Comments On USPSTF Draft Recommendation On PrEP

As previously reported, The U.S. Preventive Services Task Force (USPSTF) released its updated draft PrEP grading adding long-acting Cabotegravir (CAB-LA), the every-other-month injectable PrEP medication to the A rating already given to daily oral PrEP in 2019, making it possible to get a new HIV prevention option to people who would rather take a shot […]
Statement 12.20.2022

VICTORY: Congress Urges CDC to Expand Equitable National PrEP Access

Washington D.C.- Heeding the calls of PrEP4All, community advocates, and the Biden Administration, today Congress included as part of its fiscal year (FY) 2023 budget a call for the Centers for Disease Control and Prevention (CDC) to expand equitable national PrEP access (pg. 25) in order to end the HIV epidemic.

View All